BofA lifts target for ICON stock from USD 160 to USD 185

Published on 10/20/2026 at 13:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

ICON stock faces October 27 results after Q2 revenue of USD 2.06 billion. BofA lifted its target to USD 185 from USD 160 on October 9, 2026.

ICON reporting schedule and targets

ICON scheduled its third-quarter results for October 27, 2026.
BofA raised its target from USD 160 to USD 185 on October 9, 2026.
ICON stock trades at EUR 150.08 at 1:31 p.m. CEST at Lang & Schwarz on October 20, 2026.
Second-quarter revenue reached USD 2.06 billion for the period ended June 30, 2026.

ICLR, IE0005711209, Illustration mit AI erstellt.

ICON plc (IE0005711209) was trading at EUR 150.08 at Lang & Schwarz on October 20, 2026, at 1:31 p.m. CEST. The next company event is its third-quarter results release on October 27, 2026, followed by a conference call on October 28, 2026, according to ICON plc.

Analyst target moves higher

On October 9, 2026, BofA analyst Lu Li upgraded ICON from Underperform to Neutral and raised the price target from USD 160 to USD 185, as Markets Insider reported. The stated rationale included healthier contract research demand and sustained direct-fee bookings.

Second-quarter earnings set the base

For the quarter ended June 30, 2026, ICON reported revenue of USD 2.06 billion and consolidated net income of USD 72.58 million. Revenue was up 1.20 percent year over year, while operating profit was USD 137.83 million, according to Business Quant. The figures give the October results a clear comparison point: revenue growth continued, but reported earnings remained much smaller than sales.

What does the target change mean?

The USD 25 increase in BofA's target represents a 15.63 percent rise from USD 160. The new target is an analyst view rather than company guidance, while the October 27 release will provide the next operating update. ICON operates as a clinical research organization offering outsourced development and commercialization services to pharmaceutical, biotechnology, medical device and public-sector customers, according to ICON plc.

Three dates shape the timeline

On June 30, 2026, ICON reported USD 2.06 billion in quarterly revenue. On October 8, 2026, the company scheduled its third-quarter release after market close for October 27, 2026. On October 9, 2026, BofA lifted its target from USD 160 to USD 185.

Next dates for investors

ICON's next reporting date is October 27, 2026, after the market closes, and its conference call is scheduled for October 28, 2026, at 8:00 a.m. ET, according to MarketBeat.

Euro quote before the results

ICON's market capitalization was USD 13.0 billion and its 52-week range was USD 66.57 to USD 203.91 as of October 19, 2026. The stock was trading at EUR 150.08 at Lang & Schwarz on October 20, 2026, at 1:31 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of ICON stock.